RIPK1-IN-33

CAT: 0013-GTR19264060-01Size: 10 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19264060-01Size:10 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

RIPK1-IN-33 is an orally active RIPK1 inhibitor with excellent blood-brain barrier permeability, exhibiting an IC50 of 0.115 μM. It demonstrates significant anti-ferroptosis activity, radical scavenging capability (IC50= 123.3 μM), and anti-lipid peroxidation effects (IC50= 9.72 μM) . In transient middle cerebral artery occlusion (tMCAO) models, it significantly reduces cerebral infarct volume and improves neurological scores. RIPK1-IN-33 is suitable for ischemic stroke research.

Field of Research

Cell Biology, Signal Transduction

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR18798443-01	RIPK1 \| RIP1 Recombinant Rabbit mAb
GTR19219215-01	RIPK1-IN-17
GTR19186104-01	RIPK1-IN-14
GTR19185823-01	RIPK1-IN-11
GTR18582835-01	RIPK1 Antibody
GTR19273584-01	RIPK1-IN-34
GTR19263827-01	RIPK1-IN-32
GTR19258103-01	RIPK1-IN-29
GTR19238708-01	RIPK1-IN-25
GTR19238681-01	RIPK1-IN-24

Alternative Products

Catalog	Name
T211713-01	RIPK1-IN-33
574852-01	RIPK1
M33106-01	RIPK1-IN-4
HY-179235	RIPK1-IN-37
ASD98244-01	RIPK1-IN-7
HY-162097	RIPK1-IN-20
HY-126296	RIPK1-IN-3
HY-169107	RIPK1-IN-25
T211437-01	RIPK1-IN-32
T204483-01	RIPK1-IN-28

RIPK1-IN-33

Related Products

Alternative Products

Popular Products